• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Itching Sensation (1943); Rash (2033); Swelling (2091); Patient Problem/Medical Problem (2688)
Event Date 07/05/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient had a venaseal procedure carried out on the left leg on july 1st.By july 8th, the left leg was reported to have swollen and was red and itchy.On july 10th, the rash was reported to have spread to the entire body and became brighter and the itchiness increased.Patient consulted with the vascular surgeon, primary doctor, rhuematologist and immunologist.High doses of prednisone were prescribed by the immunologist which has led to a decrease in the itchiness.
 
Manufacturer Narrative
Information related to this event previously reported in 9612164-2019-02815 additional information: patient had entire great saphenous vein (gsv) treated with venaseal.One day post procedure the patient received an infusion for the pre-existing rheumatoid arthritis (ra).3 days post infusion the patient broke out in mild hives and itching over her trunk, shoulders and arms patient also has some mild redness over the venaseal treated vein.The physician carrying out the infusion deemed the cause was secondary to the infusion treatment and not the venaseal treatment and placed her on oral steroids and pain medication.The venaseal physician believes this is the case as well.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8845711
MDR Text Key152779217
Report Number9612164-2019-03142
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/04/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-